Previous studies have reported that cognitively healthy older adults at risk for cognitive impairment had higher blood concentrations of GFAP compared to control participants; moreover, elevated blood concentrations were associated with cognitive decline and dementia (17), supporting our study’s conclusions. The gene discussed is GFAP; the disease is dementia.